David Jipp

[David Jipp @jipp_david]

@krassenstein Welcome to Canada

[David Jipp @jipp_david]

@barbarismcrit Wouldn’t there be some form of condensation or liquid on the gun that just came from outside and could’ve been in the snow?

[David Jipp @jipp_david]

@DueDoctor @dudus_777 What’s a drug discovery company using AI that you feel comfortable with?

[David Jipp @jipp_david]

@mcuban @ISGomez Using paper is old school but it doesn’t glitch. 😀

[David Jipp @jipp_david]

@Wealthsimple wouldn’t you know a company? I was watching carefully dropped good news just before the market open. Very frustrating not be able to capitalize on the news. Any suggestions for other Canadian brokers?? Has anyone heard how good MooMoo

[David Jipp @jipp_david]

@dom_lucre ALL CAPS IS A PARODY!!

[David Jipp @jipp_david]

@GeneInvesting @FunnyGirlTrades What’s with the tariff change after hours. Biotech gets tanked when the report says it’s included in tariffs than 15 minutes once after hours closed, it was announced they are not included.

[David Jipp @jipp_david]

@GeneInvesting Haha. I bet the same close price. I’ve seen this before where 666 seems to be some game for market makers. I’m probably wrong but someone who has seen their stock price go down so much and see a close at 666 pushes them over the edge to offload their stock.

[David Jipp @jipp_david]

@yaireinhorn @intelliatx @US_FDA @OnkTherapeutics @KyvernaT @SparingVision @LauraSepplore Yes. I did see that when it came out. I thought once the first hit came on the day they announced it would stable out. I know stock price is not the same as value of the company but geez, this is ridiculous. I appreciate your insight though!

[David Jipp @jipp_david]

@GeneInvesting Seriously, Anthony! What’s going on with NTLA? is there something seriously wrong with the data?

[David Jipp @jipp_david]

@yaireinhorn any thoughts what’s going on with NTLA? Did anything in the data change or did someone get ill taking the drug?

[David Jipp @jipp_david]

@GeneInvesting @Alex___VA I am with you on that. Short selling has been quite low the last few days. I think the drop has a lot to do with consumer confidence.

[David Jipp @jipp_david]

@Alex___VA @GeneInvesting Unless there are catalysts shorts, don’t need to cover. as you mentioned, all cards have been put on the table.

[David Jipp @jipp_david]

@NikoMcCarty @AsimovPress @ScienceMagazine I take it you are referring to germ editing and not in/ex Vivo therapies

[David Jipp @jipp_david]

@DOGE In the spirit of Make Americans Healthy adopt some of the new technology to actually cure illness instead of expensive drugs for a shortened lifetime. I grew up in the digital age and now my granchildren will live to see cancer and other maladies cured for good! Less regulations

[David Jipp @jipp_david]

@longtermchair @ARKInvest One would think the new government cost cutters would appreciate this form of cutting a lifetime of care for a one and done solution but I think greed and drug companies protectionist attitude will be a hard nut to crack

[David Jipp @jipp_david]

@GeneInvesting Not a big fan on how trump communicates but a timely message from him such as “We are going to make Biotech great again! We have the smartest scientists in the world and with the smartest president it’s going to be BIGLY HUGE! America will not fall behind!

[David Jipp @jipp_david]

@GeneInvesting Regarding acquisition’s one would think even the rumour of one would cause short sellers to think twice before continuing. I guess most would be hedge funds who gain both ways. As a retail short an acquisition could be difficult to bear if it came about

[David Jipp @jipp_david]

@GeneInvesting He definitely has researched the company for sure. Just a bit wary of investors who have their handle of the stock they are commenting on.

[David Jipp @jipp_david]

@GeneInvesting Something should happen to these promising companies who are struggling to make a real difference. At least it’s not a cash issue with NTLAfor a couple years. You are not ntlaguy in secret are you? Haha. He’s convinced a merger with Regeneron is coming

[David Jipp @jipp_david]

@GeneInvesting What do you mean by phone calls to JP M? Complaining about the high short interest? The incoming administration, in my opinion, will be more favourable to one and done therapy and setting its guns on other inefficiencies in the healthcare system